🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Tig Advisors - Q2 2023 13F Filings

TI

Tig Advisors, LLC

CIK: 0001358253
Address: New York New York C/O Alti Global, Inc. 22 Vanderbilt Avenue, 27Th Floor
$1.79 B
Portfolio Value
48
Assets Held
Reporting Period: Q2 2023
Filing Status:
Active
Last Updated: 02/17/2026

Portfolio Summary (Q2 2023)

View Full Portfolio Analysis

Top Buys

Q2 2023
1. Seagen
+$125.96 M
2. Iveric Bio
+$114.26 M
4. Vmware
+$68.29 M
5. Syneos Health
+$57.87 M

Top Sells

Q2 2023
1. Oak Str Health
−$153.38 M
2. Life Storage
−$143.85 M
3. Maxar Technologies
−$63.64 M
5. Arconic Corporation
−$37.98 M

Asset Allocation

Stocks/ETFs
+28.51%
$1.62 B 90.52%
Options
+60.83%
$126.84 M 7.10%
Debt
$0 0.00%
Other
+75.22%
$42.58 M 2.38%

Sector Allocation (Stocks)

Tig Advisors Q2 2023 Filing Summary

Tig Advisors, LLC filed its 13F report for Q2 2023 on August 14, 2023. The portfolio totaled 1.79 B reflecting a +31.22% change from the prior quarter, spanning 48 assets. Allocations were 90.5% Equities, 7.1% Options, and 0.0% Debt. The top 10 holdings comprised 77.4% of the portfolio, with Financials as the largest sector allocation. Quarterly activity included 22 new positions and 23 complete exits.

Report Type

Status

Data Summary

Items:

Total Value:

Actions

Issuer Name Class Value Shares Option Type

FAQs for Tig Advisors’s Q2 2023 Filing

Tig Advisors submitted their Form 13F-HR for the Q2 2023 period on 08/14/2023. This was the only submission for the quarter.

In the Q2 2023 filing, Tig Advisors reported a managed portfolio value of 1.79 B, consisting of 48 individual positions.

This page displays the raw filing documents. To see which stocks Tig Advisors bought or sold during Q2 2023, please visit Tig Advisors's Portfolio Analysis page.